Roberto Anderson
Cerebras Systems Inc. designs and manufactures artificial intelligence chips, competing directly with Nvidia in the market for accelerated compute hardware. On Wednesday, June 25, the company filed its first earnings report as a public company, beating analyst expectations on both revenue and net loss, and the market sold the stock off sharply anyway.
At a Glance
- Cerebras Systems (NASDAQ: CBRS) closed at 188.56 USD, off 17.16% on the day
- Market capitalization: 49.79 billion USD
- 52-week range: 185.22 to 386.34
- RSI: 34.13, approaching oversold territory
- Shares sit roughly 4% above the IPO price of 185 USD
| Price | 188.56 USD |
|---|---|
| Day change | -38.91 (-17.16%) |
| 52-week range | 185.22 – 386.34 |
| Market cap | $49.79B |
| RSI (14) | 34.13 |
| Volume | 14,583,022 |
Earnings Beat, Stock Breaks Down
First quarter revenue came in at 193.4 million USD, about 10 million ahead of the analyst consensus compiled by Visible Alpha. The adjusted net loss narrowed to 2.48 million USD, also better than Wall Street had modeled. By the conventional scorecard, that is a clean beat on both lines in a company's debut quarter as a public issuer.
The reaction was anything but conventional. CBRS dropped sharply in early Wednesday trading, touching its lowest level since the stock began trading last month. By the close, shares had shed 17.16%, landing at 188.56 USD and wiping out weeks of gains above the IPO price in a single session.
The driver of the selloff appears to be margin guidance rather than the historical numbers. Cerebras said it expects adjusted gross margins of 36% to 38% in the current quarter, a meaningful step down from the 47% it posted in the first quarter. For a company priced at a premium on the expectation of rapid expansion, a near 10-percentage-point compression in gross margin in a single quarter is a significant signal, regardless of the revenue beat.
What Morgan Stanley Said
Not every analyst read the release as a warning. Morgan Stanley raised its price target on CBRS to 273 USD from 250 USD on Wednesday, telling clients that demand for Cerebras chips remains strong and that nothing in the numbers was genuinely disappointing. The analysts floated the possibility that management is being deliberately conservative with its margin outlook as the company finds its footing in its first few quarters of public reporting, a fairly common pattern among recently listed technology issuers.
That target implies roughly 45% upside from Wednesday's close, a gap that reflects the conviction of the bull case rather than any change in the underlying business. Whether that conviction is rewarded depends almost entirely on whether the margin compression is a one-time transition cost or the start of a structural trend.
What the Numbers Say
Valuation
At a market cap of 49.79 billion USD and a price of 188.56 USD, Cerebras carries no conventional P/E ratio: the company remains unprofitable, and EPS figures are not applicable in the traditional sense given the adjusted loss position. Valuation rests entirely on revenue multiples and the growth trajectory implied by that first quarter beat. The 52-week high of 386.34 USD, set earlier in the trading period, shows how aggressively the market had priced in an optimistic scenario. The current price, near the 52-week low of 185.22 USD, tells a different story.
Momentum
An RSI of 34.13 places CBRS just above the conventional oversold threshold of 30. The reading reflects the severity and speed of the selloff from post-IPO highs: shares are now down nearly 40% from their first-day closing price. At this RSI level, the stock is not yet flashing a technical buy signal, but it is entering a zone where momentum-oriented sellers tend to exhaust themselves. The trend is clearly downward, and the burden of proof sits with the bulls.
Yield
Cerebras pays no dividend. The company is in investment mode, directing capital toward chip development and manufacturing scale rather than shareholder distributions. Income-oriented investors have no yield to buffer against the price volatility evident in Wednesday's session.
Bull Case Against Bear Case
The Bull Case
Cerebras beat estimates in its first quarter as a public company, which matters. Morgan Stanley's revised price target of 273 USD reflects confidence that demand for the company's AI chips is genuine and growing. If management is indeed sandbagging margin guidance to set a low bar for future beats, the Q2 report could reverse sentiment quickly. The company's revenue run rate, extrapolating from the 193.4 million USD first quarter, points toward a business with real scale potential in a market where AI compute demand shows no sign of easing.
The Bear Case
A drop from 47% adjusted gross margins to a guided range of 36% to 38% in a single quarter is a concrete and quantifiable deterioration, not a narrative risk. At a market cap approaching 50 billion USD with no earnings, the stock requires a nearly perfect execution story. The 52-week high of 386.34 USD was more than double the current price, meaning a large portion of the investor base that bought in above 200 USD is underwater. That creates persistent overhead supply. The IPO price of 185 USD is now the floor, and the stock is barely above it.
Frequently Asked Questions
Why did Cerebras stock fall after a quarterly earnings beat?
The selloff centered on forward guidance rather than the historical results. Cerebras projected adjusted gross margins of 36% to 38% for the current quarter, down sharply from 47% in the first quarter. Investors reacted to the anticipated margin compression even though the Q1 revenue and loss numbers both came in better than analyst estimates.
How far is CBRS from its IPO price?
As of the close on Wednesday, June 25, Cerebras shares at 188.56 USD sit approximately 4% above the IPO price of 185 USD. The stock has fallen roughly 40% from its first-day closing price.
What is Morgan Stanley's price target for Cerebras?
Morgan Stanley raised its CBRS price target to 273 USD from 250 USD on Wednesday, June 25, citing strong chip demand and the likelihood that management guidance is conservative.
Does Cerebras pay a dividend?
No. Cerebras Systems does not pay a dividend. The company is pre-profitability and is allocating capital to product development and business growth.
Where the Stock Goes From Here
Cerebras enters the back half of 2025 in an uncomfortable position: a clean earnings beat that the market treated as a sell signal, an RSI reading that stops just short of oversold, and a price that has erased nearly all of the gains made since the IPO. The margin compression question will not be settled until the next quarterly report. Until then, the 185 USD IPO price is the technical line that separates a painful correction from something more serious.
Christina Shaw
Franklin Gonzales